Notably, human CXCL10 levels are increased in progranulin-linked FTD (81), AD (113), and amnestic mild cognitive impairment (113), either in the cerebrospinal fluid or in astrocytes (62), and these levels correlate with cognitive performance (113). The gene discussed is GRN; the disease is Alzheimer disease.